FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3005118034> ?p ?o ?g. }

• W3005118034 endingPage "361" @default.
• W3005118034 startingPage "349" @default.
• W3005118034 abstract "The aim of this study was the development of griseofulvin (GRI) loaded β-cyclodextrin (β-CD) based nanosponges for bitter taste masking, improving dissolution rate and oral bioavailability. Plain NS (NS1 NS2 and NS3) were fabricated by reacting β-CD with the cross-linker diphenyl carbonate at different molar ratios (1:2, 1:4 and 1:6, respectively) using ultrasonication method. The NS2 provided both highest %yield and GRI solubilization enhancement. Thus, the drug was loaded in NS2 at different NS2: drug weight ratios in presence or absence of 0.25%w/w polyvinylpyrolidone (PVP k30). The GRI loaded NS (F1) that provided highest drug loading capacity and entrapment efficiency (47.20 ± 0.38%, 84.91 ± 0.30%, respectively) was morphologically examined using scanning electron microscopy (SEM). Also, Particle size, zeta potential, differential scanning calorimetry (DSC), Fourier transform infra-red (FT-IR), nuclear magnetic resonance (NMR) spectroscopy, in-vitro release, taste masking potential were evaluated. Moreover, in-vivo Pharmacokinetic studies were performed on rats. The F1 showed particle size 665.9 ± 13.8 nm and zeta potential -21.5 ± 0.7 mV. The DSC and FT-IR analysis confirmed the complexation of GRI with NS2. Nanosponges (F1) provided 3.19, folds increase in dissolution efficiency %, 2.13 and 3.78 folds increase in Cmax and AUC0-48 compared to plain GRI. Taste masking evaluation confirmed the potential of GRI nanosponges (F1) in masking the bitter taste of GRI completely. The study confirmed that complexation of GRI with NS would be a viable approach for masking the bitter taste of GRI and improving oral bioavailability, that Cmax, Tmax and AUC 0-48 were significantly higher for the developed formulation (F1)." @default.
• W3005118034 created "2020-02-14" @default.
• W3005118034 creator A5001491807 @default.
• W3005118034 creator A5009922454 @default.
• W3005118034 creator A5014007931 @default.
• W3005118034 date "2020-03-01" @default.
• W3005118034 modified "2023-10-18" @default.
• W3005118034 title "Formulation and evaluation of cyclodextrin-based nanosponges of griseofulvin as pediatric oral liquid dosage form for enhancing bioavailability and masking bitter taste" @default.
• W3005118034 cites W1498305210 @default.
• W3005118034 cites W1589237817 @default.
• W3005118034 cites W1720056974 @default.
• W3005118034 cites W1766205310 @default.
• W3005118034 cites W1968597614 @default.
• W3005118034 cites W1977072597 @default.
• W3005118034 cites W1977549443 @default.
• W3005118034 cites W1992580858 @default.
• W3005118034 cites W1993765180 @default.
• W3005118034 cites W1995981426 @default.
• W3005118034 cites W1998621999 @default.
• W3005118034 cites W2000352722 @default.
• W3005118034 cites W2000550350 @default.
• W3005118034 cites W2017985332 @default.
• W3005118034 cites W2029908607 @default.
• W3005118034 cites W2029966127 @default.
• W3005118034 cites W2030721954 @default.
• W3005118034 cites W2036949824 @default.
• W3005118034 cites W2040020692 @default.
• W3005118034 cites W2044277719 @default.
• W3005118034 cites W2046017608 @default.
• W3005118034 cites W2048325024 @default.
• W3005118034 cites W2054745605 @default.
• W3005118034 cites W2057782877 @default.
• W3005118034 cites W2061963139 @default.
• W3005118034 cites W2065012672 @default.
• W3005118034 cites W2065162705 @default.
• W3005118034 cites W2068903617 @default.
• W3005118034 cites W2073394985 @default.
• W3005118034 cites W2075727182 @default.
• W3005118034 cites W2079407952 @default.
• W3005118034 cites W2083252853 @default.
• W3005118034 cites W2087710066 @default.
• W3005118034 cites W2093576191 @default.
• W3005118034 cites W2105659479 @default.
• W3005118034 cites W2117774828 @default.
• W3005118034 cites W2129039800 @default.
• W3005118034 cites W2135130257 @default.
• W3005118034 cites W2151114776 @default.
• W3005118034 cites W2153230127 @default.
• W3005118034 cites W2156483611 @default.
• W3005118034 cites W2162250373 @default.
• W3005118034 cites W2164413075 @default.
• W3005118034 cites W2167677977 @default.
• W3005118034 cites W2534083157 @default.
• W3005118034 cites W2544832710 @default.
• W3005118034 cites W2747771949 @default.
• W3005118034 cites W2790259157 @default.
• W3005118034 cites W2805440312 @default.
• W3005118034 cites W2891083494 @default.
• W3005118034 cites W3024152446 @default.
• W3005118034 doi "https://doi.org/10.1016/j.jsps.2020.01.016" @default.
• W3005118034 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7078523" @default.
• W3005118034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32194337" @default.
• W3005118034 hasPublicationYear "2020" @default.
• W3005118034 type Work @default.
• W3005118034 sameAs 3005118034 @default.
• W3005118034 citedByCount "55" @default.
• W3005118034 countsByYear W30051180342020 @default.
• W3005118034 countsByYear W30051180342021 @default.
• W3005118034 countsByYear W30051180342022 @default.
• W3005118034 countsByYear W30051180342023 @default.
• W3005118034 crossrefType "journal-article" @default.
• W3005118034 hasAuthorship W3005118034A5001491807 @default.
• W3005118034 hasAuthorship W3005118034A5009922454 @default.
• W3005118034 hasAuthorship W3005118034A5014007931 @default.
• W3005118034 hasBestOaLocation W30051180341 @default.
• W3005118034 hasConcept C121332964 @default.
• W3005118034 hasConcept C127413603 @default.
• W3005118034 hasConcept C13965031 @default.
• W3005118034 hasConcept C142724271 @default.
• W3005118034 hasConcept C147789679 @default.
• W3005118034 hasConcept C155574463 @default.
• W3005118034 hasConcept C155672457 @default.
• W3005118034 hasConcept C160892712 @default.
• W3005118034 hasConcept C171250308 @default.
• W3005118034 hasConcept C178790620 @default.
• W3005118034 hasConcept C181389837 @default.
• W3005118034 hasConcept C185592680 @default.
• W3005118034 hasConcept C187530423 @default.
• W3005118034 hasConcept C192562407 @default.
• W3005118034 hasConcept C22979827 @default.
• W3005118034 hasConcept C2779433975 @default.
• W3005118034 hasConcept C2779819575 @default.
• W3005118034 hasConcept C39519442 @default.
• W3005118034 hasConcept C42360764 @default.
• W3005118034 hasConcept C43617362 @default.
• W3005118034 hasConcept C71924100 @default.
• W3005118034 hasConcept C86181022 @default.
• W3005118034 hasConcept C88380143 @default.

• next